Using HFNC in Bronchiolitis
Launched by KAYSERI TRAINING AND RESEARCH HOSPITAL · Nov 14, 2017
Trial Information
Current as of August 31, 2025
Completed
Keywords
ClinConnect Summary
Acute bronchiolitis results from inflammation of the bronchioles and is usually caused by a viral infection. It is most common in children younger than 2 years old and is one of the most frequent reasons why a child is admitted to hospital. There is no established, specific therapy for acute bronchiolitis and it is commonly treated using supplemental oxygen and by ensuring that the patient remains hydrated.
Oxygen therapy can be applied using a low- or high-flow oxygen delivery system. For example, a diffuser mask (OxyMask) is a low-flow delivery system, which is capable of delivering up t...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Included patients were aged between 1 and 24 months and had been diagnosed with moderate or severe acute bronchiolitis. They were admitted to the ICU, requiring supplemental oxygen, because their SpO2 measurements were less than 94% while breathing room air.
- Exclusion Criteria:
- • Any patients requiring immediate respiratory support (non-invasive or invasive mechanical ventilation, altered mental status, or apnea at presentation), those already admitted to the ICU due to respiratory failure, those with underlying chronic lung disease or cardiovascular disorders, those with obstructions of the upper respiratory tract, and those with cranial malformations were excluded.
About Kayseri Training And Research Hospital
Kayseri Training and Research Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Located in Kayseri, Turkey, the hospital combines comprehensive patient care with a strong emphasis on education and research, fostering an environment where cutting-edge treatments and therapies can be developed and evaluated. With a commitment to ethical standards and regulatory compliance, Kayseri Training and Research Hospital collaborates with various stakeholders to conduct high-quality clinical studies, contributing to the broader medical community and enhancing the quality of care provided to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials